Cochrane Overview: Biologics more effective than placebo in treating rheumatoid arthritis
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: A Cochrane overviewCMAJ. 2009 Nov 24;181(11):787-96. Epub 2009 Nov 2.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
This network meta-analysis identified 6 Cochrane Collaboration systematic reviews, comprised in total of 31 studies. These reviews examined the safety and benefits of 6 biologics in patients with rheumatoid arthritis (abatacept, adalimumab, anakinra, etanercept, infliximab and rituximab). The primary outcomes of this study were safety (number of withdrawals related to adverse effects) and benefit ...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE